Ignite Creation Date:
2025-12-24 @ 5:59 PM
Ignite Modification Date:
2026-02-20 @ 1:32 PM
Study NCT ID:
NCT06382168
Status:
RECRUITING
Last Update Posted:
2025-09-03
First Post:
2024-04-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
Sponsor:
Delta-Fly Pharma, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D19-11186
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None